Findell Capital Management
Latest statistics and disclosures from Findell Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LQDA, ESTA, ROOT, DAVE, TPB, and represent 78.72% of Findell Capital Management's stock portfolio.
- Added to shares of these 10 stocks: ROOT (+$13M), CELH (+$9.6M), DAVE (+$7.1M), LRN (+$5.8M), ADMA (+$5.5M), TPB, SGHC, VOR, GEO, ABVX.
- Started 4 new stock positions in CELH, LRN, VOR, ADMA.
- Reduced shares in these 6 stocks: ODP (-$15M), ESTA (-$12M), MLYS (-$7.3M), BTU (-$6.2M), LQDA, SEZL.
- Sold out of its positions in BTU, SEZL, ODP.
- Findell Capital Management was a net buyer of stock by $5.0M.
- Findell Capital Management has $348M in assets under management (AUM), dropping by 37.26%.
- Central Index Key (CIK): 0001814465
Tip: Access up to 7 years of quarterly data
Positions held by Findell Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Findell Capital Management
Findell Capital Management holds 15 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Liquidia Corporation Com New (LQDA) | 41.7 | $145M | -3% | 4.2M | 34.49 |
|
| Establishment Labs Holdings Ord (ESTA) | 23.7 | $82M | -12% | 1.1M | 72.88 |
|
| Root Cl A New (ROOT) | 4.9 | $17M | +291% | 235k | 72.23 |
|
| Dave Class A Com New (DAVE) | 4.5 | $16M | +84% | 70k | 221.41 |
|
| Turning Pt Brands (TPB) | 4.0 | $14M | +41% | 127k | 108.40 |
|
| Oportun Finl Corp (OPRT) | 3.9 | $14M | 2.6M | 5.29 |
|
|
| Super Group Sghc Ord Shs (SGHC) | 3.2 | $11M | +40% | 940k | 11.95 |
|
| Geo Group Inc/the reit (GEO) | 3.0 | $11M | +16% | 650k | 16.12 |
|
| Celsius Hldgs Com New (CELH) | 2.8 | $9.6M | NEW | 210k | 45.74 |
|
| eHealth (EHTH) | 1.9 | $6.5M | +15% | 1.4M | 4.60 |
|
| Abivax Sa Sponsored Ads (ABVX) | 1.9 | $6.5M | +20% | 48k | 134.85 |
|
| Stride (LRN) | 1.7 | $5.8M | NEW | 90k | 64.93 |
|
| Adma Biologics (ADMA) | 1.6 | $5.5M | NEW | 300k | 18.24 |
|
| Vor Biopharma Com New (VOR) | 0.9 | $3.0M | NEW | 231k | 13.08 |
|
| Mineralys Therapeutics (MLYS) | 0.5 | $1.8M | -80% | 50k | 36.29 |
|
Past Filings by Findell Capital Management
SEC 13F filings are viewable for Findell Capital Management going back to 2023
- Findell Capital Management 2025 Q4 filed Feb. 17, 2026
- Findell Capital Management 2025 Q3 filed Nov. 14, 2025
- Findell Capital Management 2025 Q2 filed Aug. 14, 2025
- Findell Capital Management 2025 Q1 filed May 15, 2025
- Findell Capital Management 2024 Q4 filed Feb. 14, 2025
- Findell Capital Management 2024 Q3 filed Nov. 14, 2024
- Findell Capital Management 2024 Q2 filed Aug. 14, 2024
- Findell Capital Management 2024 Q1 filed May 15, 2024
- Findell Capital Management 2023 Q4 restated filed Feb. 21, 2024